Marchenkova Anna, Vilotti Sandra, Ntamati Niels, van den Maagdenberg Arn Mjm, Nistri Andrea
Neuroscience Department, International School for Advanced Studies (SISSA), Trieste, Italy.
Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands Department of Human Genetics, Leiden University Medical Centre, Leiden, the Netherlands.
Mol Pain. 2016 May 12;12. doi: 10.1177/1744806916646110. Print 2016.
On trigeminal ganglion neurons, pain-sensing P2X3 receptors are constitutively inhibited by brain natriuretic peptide via its natriuretic peptide receptor-A. This inhibition is associated with increased P2X3 serine phosphorylation and receptor redistribution to non-lipid raft membrane compartments. The natriuretic peptide receptor-A antagonist anantin reverses these effects. We studied whether P2X3 inhibition is dysfunctional in a genetic familial hemiplegic migraine type-1 model produced by introduction of the human pathogenic R192Q missense mutation into the mouse CACNA1A gene (knock-in phenotype). This model faithfully replicates several properties of familial hemiplegic migraine type-1, with gain-of-function of CaV2.1 Ca(2+) channels, raised levels of the algogenic peptide calcitonin gene-related peptide, and enhanced activity of P2X3 receptors in trigeminal ganglia.
In knock-in neurons, anantin did not affect P2X3 receptor activity, membrane distribution, or serine phosphorylation level, implying ineffective inhibition by the constitutive brain natriuretic peptide/natriuretic peptide receptor-A pathway. However, expression and functional properties of this pathway remained intact together with its ability to downregulate TRPV1 channels. Reversing the familial hemiplegic migraine type-1 phenotype with the CaV2.1-specific antagonist, ω-agatoxin IVA restored P2X3 activity to wild-type level and enabled the potentiating effects of anantin again. After blocking calcitonin gene-related peptide receptors, P2X3 receptors exhibited wild-type properties and were again potentiated by anantin.
P2X3 receptors on mouse trigeminal ganglion neurons are subjected to contrasting modulation by inhibitory brain natriuretic peptide and facilitatory calcitonin gene-related peptide that both operate via complex intracellular signaling. In the familial hemiplegic migraine type-1 migraine model, the action of calcitonin gene-related peptide appears to prevail over brain natriuretic peptide, thus suggesting that peripheral inhibition of P2X3 receptors becomes insufficient and contributes to trigeminal pain sensitization.
在三叉神经节神经元上,疼痛感知性P2X3受体通过其利钠肽受体-A被脑钠肽持续抑制。这种抑制与P2X3丝氨酸磷酸化增加以及受体重新分布到非脂筏膜区室有关。利钠肽受体-A拮抗剂阿南汀可逆转这些效应。我们研究了在通过将人类致病性R192Q错义突变引入小鼠CACNA1A基因(敲入表型)产生的1型遗传性家族性偏瘫性偏头痛模型中,P2X3抑制是否功能失调。该模型忠实地复制了1型家族性偏瘫性偏头痛的若干特性,包括CaV2.1钙通道功能增强、致痛肽降钙素基因相关肽水平升高以及三叉神经节中P2X3受体活性增强。
在敲入神经元中,阿南汀不影响P2X3受体活性、膜分布或丝氨酸磷酸化水平,这意味着持续的脑钠肽/利钠肽受体-A途径抑制无效。然而,该途径的表达和功能特性及其下调TRPV1通道的能力保持完整。用CaV2.1特异性拮抗剂ω-芋螺毒素IVA逆转1型家族性偏瘫性偏头痛表型后,P2X3活性恢复到野生型水平,并且阿南汀的增强作用再次显现。阻断降钙素基因相关肽受体后,P2X3受体表现出野生型特性,并且再次被阿南汀增强。
小鼠三叉神经节神经元上的P2X3受体受到抑制性脑钠肽和促进性降钙素基因相关肽的相反调节,二者均通过复杂的细胞内信号传导发挥作用。在1型家族性偏瘫性偏头痛模型中,降钙素基因相关肽的作用似乎超过脑钠肽,因此表明P2X3受体的外周抑制变得不足,并导致三叉神经疼痛敏化。